trending Market Intelligence /marketintelligence/en/news-insights/trending/x1t1chbhxjwaplshxk1mkg2 content esgSubNav
In This List

Alder BioPharmaceuticals names CEO

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Alder BioPharmaceuticals names CEO

Alder Biopharmaceuticals Inc. appointed Robert Azelby as president, CEO and director, effective June 13.

Azelby previously served at Juno Therapeutics Inc. as executive vice president and chief commercial officer.

Bothell, Wash.-based Alder is a clinical-stage biopharmaceutical company that discovers, develops and commercializes therapeutic antibodies.